Summary:
- Many recent advances in artificial intelligence and aging biomarkers that transpired since 2013 are converging
- Gachon University and Gil Medical Center are at the forefront of aging research in Korea
- Aging research is gaining credibility in the pharmaceutical industry and healthcare in general
- Insilico Medicine and Gachon University and Gil Medical Center have partnered to collaboratively develop biomarkers and interventions
Friday, 3rd of February, 2017, Baltimore, MD — Insilico Medicine today announced that it signed a Memorandum of Understanding (MOU) and started the first collaborative research project with one of the largest research and medical networks, Gachon University and Gil Medical Center. The intent of the long-term collaboration is to develop artificially intelligent multimodal biomarkers of aging and health status as well as interventions intended to slow down or even reverse the processes leading to the age-related loss of function.
Read more
Comments are closed.